The objective of this study is to examine whether DiabetesWise increases uptake of diabetes devices, which are empirically supported to improve glycemic and psychosocial outcomes.<h4>Methods</h4>The sample included 458 participants (M<sub>age</sub>  = 37.1, SD = 9.73; 66% female; 81% type 1 diabetes) with insulin-requiring diabetes and minimal diabetes device use at enrollment. The gene discussed is INS; the disease is diabetes mellitus.